دورية أكاديمية
Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response
| العنوان: | Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response |
|---|---|
| المؤلفون: | Derosa S., Misztak P., Mingardi J., Mazzini G., Müller H. K., Musazzi L. |
| المساهمون: | Derosa, S, Misztak, P, Mingardi, J, Mazzini, G, Müller, H, Musazzi, L |
| بيانات النشر: | Elsevier Inc. US |
| سنة النشر: | 2024 |
| المجموعة: | Università degli Studi di Milano-Bicocca: BOA (Bicocca Open Archive) |
| مصطلحات موضوعية: | Animal model, Fast-acting antidepressant, Intracellular pathway, Ketamine, Response/non-response, Stress vulnerability |
| الوصف: | Major Depressive Disorder (MDD) is a highly debilitating disorder characterized by a persistent feeling of sadness and anhedonia. Traditional antidepressants have a delayed onset of action and lack of efficacy in up to one third of patients, leading to treatment resistant depression (TRD). Recent years have witnessed a revolutionary treatment of TRD with the introduction of the fast-acting antidepressant ketamine. However, ketamine's mechanisms of action are still poorly understood. Here, we used the chronic mild stress animal model of depression on male rats to investigate the involvement of neurotrophic signaling pathways in stress vulnerability/resilience and fast antidepressant response/non-response to acute subanesthetic ketamine. We performed our analysis on both the hippocampus and the prefrontal cortex, two brain areas implicated in stress-related disorders, considering different subcellular fractions. We measured the activation by phosphorylation of protein kinase B (AKT), extracellular signal-regulated kinases (ERKs), glycogen synthase kinase-3 beta (GSK3 β), mammalian target of rapamycin (mTOR), and eukaryotic elongation factor 2 (eEF2), key effectors in the regulation of neuroplasticity and glutamatergic transmission which were previously associated to ketamine's fast antidepressant effect. We showed here for the first time that both stress and ketamine induced brain area and subcellular fraction specific changes in these pathways. Our study represents the first attempt to identify molecular mechanisms underlying the response/non-response to ketamine in an animal model of depression. This approach could give a crucial contribution to the study of etiopathogenetic mechanisms as well as to the identification of novel targets for the development of innovative therapeutic strategies. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | STAMPA |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/37793481; info:eu-repo/semantics/altIdentifier/wos/WOS:001091815900001; volume:128; issue:10 January 2024; journal:PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; https://hdl.handle.net/10281/459738Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85173169225 |
| DOI: | 10.1016/j.pnpbp.2023.110871 |
| الإتاحة: | https://doi.org/10.1016/j.pnpbp.2023.110871Test https://hdl.handle.net/10281/459738Test |
| رقم الانضمام: | edsbas.461ADD67 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.pnpbp.2023.110871 |
|---|